InternationalUSRemember you can easily switch between MIP US and MIP International at any time

CJEU Advocate General: 25 member states can agree a unitary patent deal


An important hurdle in the path of the unitary patent looks set to be dismantled after a key legal adviser at the Court of Justice of the EU said today that 25 member states should be able to press ahead with a deal without Italy and Spain

Last year the two countries asked Europe’s highest court to stop the European Council from pursuing the unitary patent package under the enhanced cooperation procedure.

The two countries are particularly unhappy about the proposal to make English, French and German the official...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

The week in IP - @mdloney's round-up: Ford, Google, Oracle, patent grants, Led Zep, trolls http://t.co/AjdMvgYP3B http://t.co/vKhF6mUyAV

May 29 2015 07:28 ·  reply ·  retweet ·  favourite
ManagingIP profile

@TGraulund @jakobballing That does seem the most likely reason. But it may backfire if companies cut back on filings!

May 29 2015 04:18 ·  reply ·  retweet ·  favourite
ManagingIP profile

@TGraulund If anyone could explain the logic behind putting fees up by this amount, in current business environment, we'd be grateful!

May 29 2015 02:58 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements